atl 1102 for DMD could be a Coy maker., page-10

The Australian Biotech Market makes no sense.
First we have IIL .: had a MC of $500 mill..high of $1.83 (no merit now 4.7c )
Then we have RAP : had a MC of $198 mill ...high of 55c ( no merit now .058 c)...cough into a mobile app and it will diagnose what's wrong with you....WOW.MC of $198 mill

SO now we have ANP...with a MC of $6 mill
WIth Acromegaly ready to be partnered.
Another Drug going through IND with FDA.
At present a drug for DMD about to get the green light for P2 clinical trials.
AEI the largest superfund in Australia wanting 20% of ANP.

ANd here we struggle at 3.5c..MC $6 mill.

GO FIGURE.!!